13,14-Dihydro-15-keto-PGE2
-
13,14-Dihydro-15-keto-PGE2
structure -
-
CAS No:
363-23-5
-
Formula:
C20H32O5
-
Chemical Name:
13,14-Dihydro-15-keto-PGE2
-
Synonyms:
Prost-5-en-1-oic acid,11-hydroxy-9,15-dioxo-,(5Z,11α)-;5-Heptenoic acid,7-[3-hydroxy-5-oxo-2-(3-oxooctyl)cyclopentyl]-;(5Z,11α)-11-Hydroxy-9,15-dioxoprost-5-en-1-oic acid;11α-Hydroxy-9,15-diketoprost-5-enoic acid;11α-Hydroxy-9,15-dioxoprost-5-enoic acid;13,14-Dihydro-15-keto-PGE2(I);13,14-Dihydro-15-keto-PGE2;13,14-Dihydro-15-oxoprostaglandin E2;13,14-Dihydro-15-ketoprostaglandin E2;15-Oxo-13,14-dihydroprostaglandin E2;13,14-Dihydro-15-oxo-PGE2;15-Oxo-13,14-dihydro-PGE2;13,14-Dihydro-15-keto-PGE2;PGEM;DKE2;13,14-Dihydro-15-dehydro-PGE2;Prostaglandin EM;DhkPGE2;128746-10-1;27415-32-3;34021-84-6;66063-53-4
- Categories:
-
CAS No:
Description
ChEBI: The 13,14-dihydro derivative of 15-oxo-prostaglandin E2.
Solid
13,14-dihydro-15-oxo-prostaglandin E2 is the 13,14-dihydro derivative of 15-oxo-prostaglandin E2. It derives from a prostaglandin E2. It is a conjugate acid of a 13,14-dihydro-15-oxo-prostaglandin E2(1-).
Characteristics
91.67000
1.88
Solid
1.1±0.1 g/cm3
538.1±45.0 °C at 760 mmHg
293.3±25.2 °C
1.504
-20ºC
Safety Information
UN 1231 3/PG 2
3
11-20/21/22-36/37/38
16-26-36
F: Flammable;Xn: Harmful;
P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, P501
H302
|Warning|H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]|P261, P264, P270, P271, P280, P301+P312, P302+P352, P304+P312, P304+P340, P305+P351+P338, P312, P321, P322, P330, P332+P313, P337+P313, P362, P363, P403+P233, P405, and P501|Aggregated GHS information provided by 38 companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.
13,14-Dihydro-15-keto-PGE2 Use and Manufacturing
Fatty Acyls [FA] -> Eicosanoids [FA03] -> Prostaglandins [FA0301]
Computed Properties
Molecular Weight:352.5
XLogP3:2.4
Hydrogen Bond Donor Count:2
Hydrogen Bond Acceptor Count:5
Rotatable Bond Count:13
Exact Mass:352.22497412
Monoisotopic Mass:352.22497412
Topological Polar Surface Area:91.7
Heavy Atom Count:25
Complexity:469
Defined Atom Stereocenter Count:3
Defined Bond Stereocenter Count:1
Covalently-Bonded Unit Count:1
Compound Is Canonicalized:Yes
Learn More Other Chemicals
-
10-hydroxy-10-(3-octa-2,5-dienyloxiran-2-yl)deca-5,8-dienoic acid
103188-12-1
-
(5E,9E)-8-hydroxy-10-[3-[(2E,5E)-octa-2,5-dienyl]oxiran-2-yl]deca-5,9-dienoic acid
103188-13-2
-
(4-benzamidophenyl) (Z)-7-[(1R,2R,3R)-3-hydroxy-2-(2-hydroxy-3-phenoxypropoxy)-5-oxocyclopentyl]hept-4-enoate
106342-69-2
-
20-dimethyl-7-thiaprostaglandin E1 methyl ester Formula
111037-12-8
-
11-deoxyprostaglandin E1 4-hydroxyphenyl ester Formula
114495-95-3
-
16,18-ethano-20-ethyl-6-oxoprostaglandin E1 leucinamide Formula
115288-30-7
-
(5S,6Z,8E,10E,12R,14Z)-5,12-Dihydroxy-20-oxo-6,8,10,14-eicosatetraenoic acid Structure
115609-68-2
-
EP 171 Structure
115825-93-9
-
What is 5,12,19-trihydroxyicosa-6,8,10,14-tetraenoic acid
117605-61-5
-
What is (E)-7-[5-chloro-2-[(E)-3-cyclohexyl-3-hydroxyprop-1-enyl]-3-hydroxycyclopentyl]hept-5-enoic acid
117708-11-9